Cargando…
DHFR Inhibitors: Reading the Past for Discovering Novel Anticancer Agents
Dihydrofolate reductase inhibitors are an important class of drugs, as evidenced by their use as antibacterial, antimalarial, antifungal, and anticancer agents. Progress in understanding the biochemical basis of mechanisms responsible for enzyme selectivity and antiproliferative effects has renewed...
Autores principales: | Raimondi, Maria Valeria, Randazzo, Ornella, La Franca, Mery, Barone, Giampaolo, Vignoni, Elisa, Rossi, Daniela, Collina, Simona |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6471984/ https://www.ncbi.nlm.nih.gov/pubmed/30909399 http://dx.doi.org/10.3390/molecules24061140 |
Ejemplares similares
-
PEG 400/Cerium Ammonium Nitrate Combined with Microwave-Assisted Synthesis for Rapid Access to Beta-Amino Ketones. An Easy-to-Use Protocol for Discovering New Hit Compounds
por: Rossino, Giacomo, et al.
Publicado: (2018) -
Urea-based anticancer agents. Exploring 100-years of research with an eye to the future
por: Listro, Roberta, et al.
Publicado: (2022) -
DISCOVERING MAN´S PAST
por: STUART, GEORGE E. -
Discovering riboswitches: the past and the future
por: Kavita, Kumari, et al.
Publicado: (2023) -
Novel Arylsulfonylhydrazones as Breast Anticancer Agents Discovered by Quantitative Structure-Activity Relationships
por: Angelova, Violina T., et al.
Publicado: (2023)